The danger of syphilitic infection to the fetus in utero, regardless of whether the maternal syphilis is active or latent, is well known. Indeed, re-treatment throughout the period of gestation is advised by the Cooperative Clinical Group8 even when the mother has received adequate antisyphilitic therapy prior to pregnancy and presents no serological or clinical evidence of this disease when she is first seen in her pregnancy. Consequently, the question of whether or not re-treatment is necessary in those patients who have become pregnant subsequent to receiving massive dose arsenotherapy by the constant intravenous-drip procedure of Hyman-and his associates" 6 is an important one.
It is the purpose of this short communication to relate the case histories and to describe the outcome of the infants of two patients who had received massive dose arsenotherapy for early syphilis a short time before the onset of pregnancy. In this paper are also included reports upon the administration of this form of therapy in two patients whose pregnancy was complicated by secondary syphilis.
Method Clinical material and methods have been fully described in earlier communications5' 1 from this clinic. In brief, the particular method of massive dose arsenotherapy employed is that of Hyman, Chargin, and Leifer" 6 Sero-reversal took place 9 weeks after treatment, the patient having become pregnant shortly before this time, presumably about the 8th week. No further antisyphilitic therapy was administered during the period of gestation, since close observation revealed the patient to be clinically and serologically free of syphilis.
Forty-seven weeks after therapy, the patient was delivered spontaneously of a normal, full-term, male infant weighing 3625 gm. The placenta weighed 675 gm. and revealed no gross or microscopic evidence of syphilis. Kahn and Wassermann reactions on the cord blood were negative. There were no stigmata of congenital syphilis. During the next 24 weeks no clinical, serological, or roentgenological evidence of syphilis developed. With the exception of a fairly severe seborrheic dermatitis, the child gained and developed normally, always appearing to be in good health. Specific data of the follow-up study are presented in Table 1 Table 2 . gm.
The Wassermann reaction returned to negative 9 weeks after treatment although complete sero-reversal was not achieved until the 19th week. Well before this time, however, the patient became pregnant, the last menstrual period occurring 123/2 weeks after therapy, or 4y2 weeks before sero-reversal.
As in the previous case described, the serology remained negative and, consequently, no further antisyphilitic therapy was given.
Fifty-three weeks after treatment, the patient was delivered by low forceps of a normal, full-term, male infant weighing 3565 gm. The placenta weighed 535 gm. and revealed no gross or microscopic evidences of syphilis. Kahn and Wassermann reactions on the cord blood were negative. Physical examination of the infant soon after birth revealed no abnormalities suggestive of congenital syphilis and during the follow-up period of 26 weeks has gained well and revealed evidence of normal physical and mental development. Details are recorded in Table 2 .
The two following cases are recorded with brevity since the patients are still in the gestational period. The reports serve only to suggest the fact that massive dose arsenotherapy may be given to patients during the early period of pregnancy. 
Discussion
Under careful observation two infants, each born of a mother who very shortly before the onset of pregnancy received massive dose arsenotherapy for early syphilis, have developed normally and have never shown signs of congenital syphilis. Moreover, in neither mother had sero-reversal taken place before conception but despite this fact the fetuses developed normally to full term. Complete serological examinations of the blood of each infant from birth until 6 months of age have been consistently negative for syphilis; likewise, no roentgenological or clinical evidence of syphilis has developed, and it seems most improbable that this disease will develop in the future in either of these children. The development of congenital syphilis after the age of 6 months in an infant who has been found at that age to be free of stigmata and who presents a negative serology is said to be very rare indeed2' ' 7' ' and in our experience has never occurred.
From the experience gained in the last two case histories presented (Case 3-M. G. and Case 4-M. R.), it would appear that the complication of syphilis by pregnancy presents no serious contraindication for treatment of early syphilis by massive dose arsenotherapy. In neither of these cases was there observed any toxic manifestation of arsenic other than those seen in the treatment of non-pregnant patients.
It must be realized, however, that the problem of treatment by massive arsenotherapy in relation to the effect on and the outcome of the fetus remains unanswered for the present. It is our plan to follow these patients carefully and, if sero-reversal takes place before the 28th to 32nd week of gestation, to withhold the use of further antisyphilitic therapy. On the other hand, if these patients are seroresistant or perchance recurrence takes place, it is obvious that intensive treatment with one of the arsenicals is indicated. Summary 1. The case histories are described of two females who had received massive dose arsenotherapy for early syphilis shordy before the onset of pregnancy. In both instances these patients were delivered of normal, full-term infants, neither of which developed clinical, serological, or roentgenological evidences of congenital syphilis during a 6 months follow-up period.
2. The treatment by means of massive dose arsenotherapy of two additional pregnant patients with secondary syphilis is described. The course of therapy in each instance was uneventful. Neither patient has delivered; consequently no data are available concerning the fetus.
